Transcripts Cypherpunk Technologies Inc.

Actions

CYPH

US52187K2006

Recherche biotechnologique et médicale

Temps Différé Nasdaq Autres places de cotation 21:55:17 09/07/2026			Varia. 5j.	Varia. 1 janv.
0,6986 ^USD	+7,31%		+4,89%	-39,78%

01/07	CYPHERPUNK TECHNOLOGIES INC. : Cantor Fitzgerald réitère son opinion positive sur le titre	ZM
18/06	Transcript : Cypherpunk Technologies Inc. - Shareholder/Analyst Call

Transcripts

18/06	Transcript : Cypherpunk Technologies Inc. - Shareholder/Analyst Call
15/12	Transcript : Leap Therapeutics, Inc. - Shareholder/Analyst Call
23/04/25	Transcript : Leap Therapeutics, Inc. - Special Call
26/03/25	Transcript : Leap Therapeutics, Inc. - Special Call
28/01/25	Transcript : Leap Therapeutics, Inc. - Special Call
15/01/25	Transcript : Leap Therapeutics, Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-15-2025 02:15 PM
23/01/24	Transcript : Leap Therapeutics, Inc. - Special Call
10/01/24	Transcript : Leap Therapeutics, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 01:30 PM
18/01/23	Transcript : Leap Therapeutics, Inc. Presents at B. Riley Securities' 3rd Annual Oncology Conference, Jan-18-2023 01:30 PM
17/01/23	Transcript : Flame Biosciences, Inc, Leap Therapeutics, Inc. - M&A Call
12/07/22	Transcript : Leap Therapeutics, Inc. - Special Call
21/01/22	Transcript : Leap Therapeutics, Inc. - Special Call
13/01/22	Transcript : Leap Therapeutics, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-13-2022 09:00 AM
17/09/21	Transcript : Leap Therapeutics, Inc. - Special Call
22/03/21	Transcript : Leap Therapeutics, Inc. - Special Call
14/01/21	Transcript : Leap Therapeutics, Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-14-2021 12:40 PM
16/06/20	Transcript : Leap Therapeutics, Inc. - Shareholder/Analyst Call
23/04/20	Transcript : Leap Therapeutics, Inc. - Special Call
06/08/19	Transcript : Leap Therapeutics, Inc. - Special Call
17/12/18	Transcript : Leap Therapeutics, Inc. - Special Call
22/10/18	Transcript : Leap Therapeutics, Inc. - Special Call